Search Results (1,008)

Wastewater treatment plants (WWTPs) not only function as receivers of per- and polyfluoroalkyl substances (PFAS) from influent streams, but also act as PFAS contributors to the environment via effluent and sewage sludge, attributed to their strong adsorption affinity and resistance to conventional wastewater treatment processes. Thus, this review aims to comprehensively analyze the occurrence, adsorption mechanisms, and environmental fate of PFAS in sewage sludge, with a particular focus on their fate during traditional sludge disposal, namely, land application, landfill, and incineration. Long-chain perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) dominate in sewage sludge from worldwide WWTPs, with increasing prevalence of short-chain compounds. Adsorption of PFAS by sewage sludge is influenced by PFAS chain length and function group, pH, ionic strength, and organic matter. Enhanced adsorption is achieved under acidic conditions and with divalent cations. In terms of PFAS behavior in conventional sludge management, land application facilitates PFAS uptake by crops, leading to bioaccumulation in the food chain and potential human exposure. Prolonged exposure to PFAS via landfilling not only significantly alters soil microbial community structures, but also yields bacterial toxicity. Effective incineration typically requires temperatures above 850–1000°C. Incomplete thermal decomposition releases toxic fluorinated by-products into the environment and generates persistent fluorinated radicals, which result in fluorinated compounds formation in further thermal treatment. In conclusion, this work highlights the significant accumulation and persistence of PFAS in sewage sludge and their concerning behavior during conventional sludge disposal. They underscore the necessity for advanced treatment technologies and managing their impact on the ecosystem. Full article

Background/Objectives: Glucagon-like peptide-1 (GLP-1), which is released by enteroendocrine L-cells, is the primary incretin hormone and plays a pivotal role in glucose regulation, appetite control, and metabolic health. While GLP-1 receptor agonists offer significant therapeutic benefits, there is a growing interest in identifying foods that can increase endogenous GLP-1 production through physiological processes. However, the physiological impact of modulating GLP-1 through diet is modest compared with activating GLP-1 receptors pharmacologically. This narrative review summarizes the latest reports on how specific food matrices and gut microbiota-dependent pathways influence GLP-1 release, emphasizing their importance in precision nutrition. Methods: Literature published between 2001 and 2026 was reviewed, including experimental, clinical, and translational studies examining the effects of foods on GLP-1 secretion, L-cell activation, nutrient-sensing receptors, microbial metabolites, and metabolic outcomes. Evidence was synthesized for food categories such as fermented dairy products, fermented vegetables, whole grains, legumes, fiber-rich root vegetables, berries, grapes, green tea, turmeric and oily fish. Results: Foods modulate endogenous GLP-1 secretion through complementary pathways involving L-cell stimulation and the activation of receptors, including FFAR2, FFAR3, GPR119, TGR5 and FFAR4 (GPR120), as well as the production of microbial metabolites. Fermented dairy products, kimchi, kefir, Jerusalem artichokes, chicory root, oats, garlic, onions, berries, grapes, green tea and oily fish support incretin regulation through microbial fermentation, the generation of short-chain fatty acids (SCFAs), bile acid signalling and the release of bioactive compounds. These food matrices shape metabolite profiles more effectively than isolated nutrients, highlighting the importance of the interaction between whole foods and the gut microbiota. Conclusions: Foods rich in fermentable substrates, polyphenols, bioactive peptides and omega-3 fatty acids are promising dietary modulators of physiological GLP-1 activity. Taking into account microbiome characteristics, metabolic phenotype and individual postprandial responses could facilitate the development of personalized nutrition strategies to help prevent and manage obesity, type 2 diabetes and related cardiometabolic disorders. Full article

Background: The incidence of ulcerative colitis (UC) continues to rise, and food-derived bioactive peptides have attracted increasing attention as potential nutritional interventions for intestinal inflammation. This study investigated the preventive effects of the adzuki bean-derived peptide IFNNDPNNHP (IP10 peptide) on dextran sulfate sodium (DSS)-induced acute colitis in mice and explored the involvement of the gut microbiota. Methods: Mice received prophylactic IP10 peptide at 100 or 200 mg·kg⁻¹. Colitis severity was assessed based on body weight, disease activity index, colon length, histopathology, and inflammatory cytokine levels. Gut microbiota composition was analyzed by 16S rRNA gene sequencing, and fecal short-chain fatty acid (SCFA) levels were quantified. Antibiotic-mediated microbiota depletion and fecal microbiota transplantation (FMT) were used to further evaluate the role of the gut microbiota. Results: Prophylactic IP10 peptide administration attenuated DSS-induced colitis, with the 200 mg·kg⁻¹ dose more effectively attenuating body weight loss and colon shortening, reducing disease activity index scores, and modulating inflammatory cytokine levels. IP10 peptide increased microbial richness and diversity, decreased the relative abundance of Escherichia-Shigella, and increased the relative abundances of SCFA-associated taxa, including norank_f__Muribaculaceae and Lachnospiraceae_NK4A136_group. It also increased fecal SCFA levels, particularly acetate and butyrate; the high dose additionally restored propionate and valerate. When the gut microbiota was depleted using antibiotics, the protective effects of the IP10 peptide were no longer detectable, whereas FMT using fecal microbiota from donors receiving the high dose of IP10 peptide attenuated colitis and increased fecal SCFA levels in recipient mice. Conclusions: IP10 peptide alleviates DSS-induced acute colitis, and this effect may be partly associated with alterations in the gut microbiota, including the enrichment of SCFA-associated taxa and increased fecal SCFA levels. These findings support its potential as a functional food ingredient for intestinal health. Full article

Osteoporosis affects over 200 million people worldwide, with postmenopausal women at the highest risk. The treatment benefits of currently available drugs are constrained by safety concerns, and they lack bidirectional regulation of bone metabolism, driving growing interest in safe dietary interventions. Milk is rich in functional components, including minerals (calcium, phosphorus), casein phosphopeptide (CPP), lactoferrin (LF), osteopontin (OPN), and milk fat globule membrane (MFGM), that promote mineral absorption, regulate bone cell activity, and support intestinal health. This review examines their dual mechanisms in bone health regulation. Directly, LF activates Wnt/MAPK pathways to enhance osteogenesis and inhibit osteoclast activity, OPN modulates mineralization, and CPP synergizes with calcium and phosphorus to support bone formation. Indirectly, these components modulate gut microbiota via the gut–bone axis, raising short-chain fatty acids, lowering intestinal pH to boost calcium absorption, repairing the intestinal barrier, and reducing systemic inflammation. Remaining challenges lie in extraction, purification, and product development. Looking forward, the field must move from cell and animal-level evidence to human clinical validation and establish robust steady-state delivery of these bioactives. Successful translation along these lines is essential to turn milk-derived components into effective, evidence-based functional foods for bone health. Full article

Total postharvest losses of fresh fruits and vegetables in tropical and subtropical agricultural systems frequently exceed 30 percent, driven by high crop perishability, limited cold-chain infrastructure, and the geographic concentration of conventional processing facilities far from production zones. This review examines the engineering principles, operational architecture, and applied performance of mobile aseptic processing platforms (MAPPs) as a decentralized strategy for postharvest stabilization of perishable agricultural commodities. MAPPs integrate in-line homogenization, high-temperature short-time (HTST) or ultra-high-temperature (UHT) thermal treatment, clean-in-place (CIP) and sterilization-in-place (SIP) cycles, and aseptic filling within transportable, modular units engineered for field deployment. Projected MAPP capacities reach up to approximately 11,300 kg (25,000 lb) per 8 h shift, while still complying with internationally recognized food safety frameworks, including HACCP, ISO 22000, and SQF. Comparative analysis with centralized processing infrastructure and earlier decentralized initiatives, including the EU Horizon 2020 Food Processing in a Box (FOX) project, indicates that mobile aseptic systems uniquely combine field mobility with the production of ambient-stable shelf-life formats independent of refrigerated distribution. Conservative impact modeling suggests that single-unit deployments may recover on the order of 3000 t of edible product annually, with corresponding water, fertilizer, and greenhouse gas externality reductions. The review synthesizes the current state of the technology, identifies engineering and socioeconomic knowledge gaps, and proposes research priorities for scaled adoption in tropical and subtropical food systems. Full article

Paraprobiotics offer safer alternatives to live probiotics without requiring cell viability. Here, heat-inactivated bacterial preparations (paraprobiotics) were produced from Lacticaseibacillus paracasei subsp. paracasei 431 (L. casei 431) using thermal treatments (65–121 °C). No viable colonies were detected by conventional plating in any treatment, and flow cytometry indicated that more than 96% of cells were membrane-compromised or dead. The most favorable condition (65 °C, 60 min) was identified using a TOPSIS multi-criteria ranking approach integrating loss of culturability with antimicrobial activity against Enterococcus faecalis and Escherichia coli with inactivation efficiency. This paraprobiotic and the corresponding probiotic were subjected to in vitro gastrointestinal digestion and colonic fermentation, followed by short-chain fatty acid (SCFA) and 16S rRNA-based gut microbiota analysis. The fecal inoculum was pooled from five healthy donors and used to run three replicate fermentation vessels per group. Both probiotic and paraprobiotic supplementation significantly increased acetate, butyrate, and total SCFA concentrations compared with the control, and propionate and valerate concentrations were also significantly higher in the paraprobiotic group than in the control. Both interventions increased Chao1 richness and Simpson diversity (p < 0.05), although Shannon diversity did not differ significantly, and induced significant shifts in beta diversity, alongside marked enrichment of butyrate- and SCFA-producing taxa such as Roseburia, Anaerostipes, and Akkermansia muciniphila. However, not all observed microbial changes were unequivocally beneficial; increases in Bilophila wadsworthia and Collinsella aerofaciens warrant cautious interpretation given their context-dependent associations with host health. Spearman correlation analysis identified positive associations between enriched taxa and SCFA concentrations, which should be interpreted as exploratory rather than evidence of causal metabolic cross-feeding. Under the conditions of this in vitro fermentation model, no statistically significant differences were detected between the viable and heat-inactivated preparations for most measured outcomes, indicating that thermal inactivation did not markedly diminish the capacity of L. casei 431 to influence gut microbial composition and short-chain fatty acid production. The multi-criteria selection strategy offers a practical approach for optimizing paraprobiotic production for functional food applications. Full article

PFCP-2-1 (polysaccharide-2-1 of Finger Citron-pickled products), a water-soluble polysaccharide enriched in galacturonic acid, was isolated from Laoxianghuang by hot water extraction and purified using DEAE-52 and agarose CL-6B chromatography. Structural analysis showed that PFCP-2-1 had a smooth surface, flakes of varying sizes and shapes, irregular ellipsoidal structures, and cylindrical-like forms, which likely represent aggregated assemblies formed by the association and curling of polysaccharide chains. It was determined to have an average molecular weight of 749.38 kDa and to consist of rhamnose, galactose, glucose, and galacturonic acid (molar ratio 0.147:0.238:0.059:0.556). FT-IR spectroscopy revealed both α- and β-pyranose configurations, while methylation and NMR analyses identified 16 types of glycosidic linkages, of which 9 were the main types, consistent with a pectic-type structure. In an ethanol-induced acute gastric ulcer mouse model, PFCP-2-1 exhibited significant mucosal protection by elevating prostaglandin E2 (PGE2), transforming growth factor-α (TGF-α), and mucin 5AC (MUC5AC) levels and upregulating Occludin and zonula occludens-1 (ZO-1) expression. It also modulated the gut microbiota by increasing the abundance of Bacteroides and Prevotella_UCG-001, and enhanced short-chain fatty acid (acetate and butyrate) levels. These findings suggest that PFCP-2-1 may exhibit a protective effect against ethanol-induced gastric damage under the conditions of this experiment, suggesting its potential for further development as a functional food ingredient. Full article

Both 2′-fucosyllactose (2′-FL) and Bifidobacterium can modulate gut health; however, whether their combination provides strain-dependent protection against colitis remains unclear. This study aimed to compare the protective effects of 2′-FL alone and in combination with Bifidobacterium longum subsp. infantis M63 or Bifidobacterium breve M16V in dextran sulfate sodium (DSS)-induced colitis. Forty-eight male C57BL/6J mice were randomly assigned to six groups: negative control, DSS model control, 5-aminosalicylic acid positive control, 2′-FL, 2′-FL + M63, and 2′-FL + M16V. The interventions were administered for two weeks, with 2.5% DSS supplied in the drinking water during the second week. Colitis-related indices, colonic histopathology, inflammatory cytokines, oxidative-stress markers, intestinal barrier-associated gene expression, gut microbiota composition, lactate, and short-chain fatty acids (SCFAs) were evaluated. Compared with the model control, 2′-FL and both synbiotic combinations ameliorated colonic tissue injury and goblet-cell loss. Both combinations significantly reduced IL-1β, whereas 2′-FL and both combinations reduced IL-6 and TNF-α. The combinations also increased catalase and glutathione peroxidase activities and decreased malondialdehyde levels. 2′-FL alone increased Occludin and RELMβ expression, whereas 2′-FL + M63 showed the strongest effects on tight-junction and mucus-barrier restoration, including increased Claudin-1, Claudin-2, ZO-1, TFF3, and MUC2 expression. All 2′-FL-containing interventions increased microbial diversity, while 2′-FL + M63 increased Bacteroidota, reduced Proteobacteria, and enriched Muribaculaceae and Ruminococcaceae. Both synbiotic combinations increased lactate and all measured SCFAs; 2′-FL + M63 produced the highest acetate level, whereas 2′-FL + M16V produced the highest propionate level, and both combinations markedly increased butyrate. These findings demonstrate strain-dependent protective effects, with 2′-FL + M63 showing the greatest overall efficacy in restoring intestinal barrier function and microbial metabolism, supporting its development as a candidate functional synbiotic food formulation. Full article

Xinjiang ranks among the key domestication origins of horses. Local nomadic ethnic groups have a long-standing tradition of consuming equine dairy products, which endows mare-derived dairy matrices with abundant, distinctive and scarce probiotic resources. Equine colostrum is rich in immunoglobulins and growth factors; nevertheless, its pharmacological activities and micro-ecological composition remain poorly characterized. This study aimed to isolate and screen native strains with cholesterol-lowering potential from Xinjiang equine colostrum and conduct a preliminary investigation into their underlying mechanisms. Following isolation and taxonomic identification, one strain of Lactobacillus helveticus, four strains of Lactiplantibacillus plantarum, and two yeast strains including Pichia fermentans and Pichia membranifaciens were obtained. All the aforementioned isolates are indigenous microorganisms naturally inhabiting mare colostrum. In vitro assays demonstrated bile salt hydrolase activity and cholesterol clearance rates ranging from 45.07% to 87.14%, with composite probiotic formulations exhibiting superior efficacy. In vivo results demonstrated that the combination formulation significantly reduced serum levels of total cholesterol, triglycerides, and low-density lipoprotein cholesterol (p < 0.05), alleviated hepatic lipid deposition, and regulated gut microbiota composition—notably by enhancing the abundance of beneficial bacteria. It also increased fecal short-chain fatty acids and decreased bile acid levels. These findings demonstrate that the native strains isolated from mare colostrum possess desirable probiotic properties and lipid-lowering bioactivities. Their unique source and natural combinatorial characteristics provide candidate-strain resources for the development of novel functional foods and nutritional supplements. Full article

Metabolic syndrome, driven by obesity, poses a significant global health burden. P. incarnata leaf polyphenol extract (PP), a crude 70% ethanol extract, exhibits potential bioactive properties, yet its efficacy and underlying mechanisms against metabolic disorders remain unclear. This study investigated effects of this extract (PP) on high-fat diet (HFD)-induced metabolic syndrome in mice and explored possible involvement of the gut–liver–adipose axis. Thirty mice were divided into five groups: ND (normal diet), HFD, PC-HFD (HFD + orlistat), PP1 (HFD + 75 mg/kg/day PP), and PP2 (HFD + 150 mg/kg/day PP). After 8 weeks, high-dose PP (PP2) significantly attenuated body weight gain, and reduced food intake, hyperlipidemia, and systemic inflammation. In addition, PP intervention altered the gut microbiota composition and was associated with enrichment of beneficial genera and elevated fecal short-chain fatty acids (SCFAs). Hepatic transcriptomics showed that PP2 extensively reversed HFD-induced transcriptional suppression, while fecal metabolomics indicated restoration of key metabolite profiles. Furthermore, PP2 markedly upregulated thermogenic gene expression in adipose tissue. Collectively, these findings suggest that PP, particularly at the high dose, ameliorated HFD-induced obesity and related metabolic disturbances; these benefits were accompanied by decreased caloric intake, changes in gut microbiota composition, hepatic transcriptomic profiles, and adipose thermogenic gene expression. Full article

Eucommia ulmoides leaves, a traditional edible and medicinal resource, are a rich source of bioactive polyphenols. In this study, male Wistar rats served as the normal control, while spontaneously hypertensive rats were randomized into model, positive control (nifedipine, 6.0 mg/kg/d), and low-, medium-, and high-dose groups receiving 1.25, 2.50, and 3.75 mL/kg/d of the polyphenol extract (n = 8/group) via intragastric gavage for 4 weeks. The extract supplementation significantly reduced systolic and diastolic blood pressure to approximately 166.33 mmHg and 113.93 mmHg, respectively, thereby improving vascular function (p < 0.05), accompanied by alleviation of lipid metabolism disorders and oxidative stress. In addition, it mitigated intestinal injury and enhanced gut barrier integrity. Notably, it reshaped the gut microbiota by enriching beneficial bacteria and suppressing harmful taxa, which is associated with increased production of short-chain fatty acids. Integrated metabolomics analysis further demonstrated that it modulated multiple metabolic pathways, particularly arachidonic acid and tryptophan metabolism, which are closely linked to vascular homeostasis, inflammation, and oxidative stress. Collectively, these findings indicate that the antihypertensive effects of the polyphenol extract are potentially linked to the regulation of the gut microbiota–metabolite axis, highlighting its promising application as a functional food ingredient for cardiovascular health. Full article

Edible insects are increasingly proposed as sustainable protein sources in animal nutrition, yet their effects on gut microbial function, intestinal safety, and systemic metabolism require comprehensive evaluation. This study investigated the impact of a diet containing 35% Tenebrio molitor meal on the functional activity of gut environment and host metabolic profiles in rats, in comparison with diets containing chicken hydrolysate or a standard laboratory diet. Female Wistar rats were fed the experimental diets for 60 days, after which fecal short-chain fatty acids (SCFAs), microbial enzyme activity, fecal water genotoxicity, and liver and spleen metabolomes were assessed. Rats fed the T. molitor diet exhibited significantly lower fecal concentrations of major SCFAs, including acetate, butyrate, valerate, and branched-chain fatty acids (BCFAs), indicating altered colonic fermentation. Both β-glucosidase and β-glucuronidase activities differed significantly between groups and were highest in the T. molitor group. β-Glucuronidase activity also decreased over time, whereas no significant group vs. time interaction was observed. Fecal water genotoxicity decreased markedly in the T. molitor group over time. Untargeted UHPLC–HRMS metabolomics revealed pronounced diet-dependent differences in metabolite profiles. In the liver, the insect-based diet was associated with the enrichment of glycerophospholipid metabolism, primary bile acid biosynthesis, and pyrimidine metabolism pathways, as well as lower abundance of metabolites assigned to riboflavin- and phenylalanine-related pathways. In the spleen, diet-associated differences involved metabolites assigned to lipid-related pathways, including glycerophospholipid, linoleic acid, and steroid-related metabolism, as well as nucleotide-associated pathways. These findings support further evaluation of complete insect-based formulations and highlight specific metabolic pathways that should be considered when evaluating the safety and physiological implications of insect-based feeds. Full article

Polygonatum cyrtonema Hua polysaccharides (PCPs) are bioactive components with antioxidant and immunomodulatory properties. However, whether the polysaccharides derived from elder Polygonatum cyrtonema exhibit superior health benefits remains unclear. This study systematically compared the in vitro fermentation characteristics, gut microbiota-modulating effects, and short-chain fatty acid (SCFA) production of PCPs extracted from three-year-old (TPP), five-year-old (FPP), and eight-year-old (EPP) plants using a human fecal fermentation model. The fermentation dynamics were evaluated by monitoring pH, OD₆₀₀, and the consumption of total and reducing sugars, while the structural degradation and compositional differences in PCPs were tracked via molecular weight distribution and monosaccharide composition analysis. The results showed that all three PCPs were degraded and utilized by gut microbiota, accompanied by decreased pH, increased OD₆₀₀, and enhanced antioxidant activities. High-throughput 16S rDNA sequencing revealed that, at the phylum level, all PCPs increased the Firmicutes/Bacteroidetes ratio. At the genus level, they reduced the abundance of harmful bacteria such as Sutterella and increased beneficial bacteria including Bifidobacterium and Megasphaera. Furthermore, gas chromatography (GC) analysis demonstrated that, compared with FPP, TPP and EPP significantly promoted the production of SCFAs. In summary, this study indicates that the in vitro fermentation characteristics and prebiotic properties of PCPs vary with growth years, and a comprehensive evaluation suggests that three-year-old Polygonatum cyrtonema Hua represents a promising raw material for the development of functional foods. Full article

Hypertension is the most common comorbidity in chronic kidney disease (CKD), affecting roughly 80–85% of patients overall and an even higher proportion in nondialysis CKD G3–G5. This narrative review examines whether, and under what clinical conditions, fruits, vegetables, and legumes can be used safely in adults with hypertensive CKD, especially nondialysis CKD G3–G5, as well as moderate to severe loss of kidney function, paying close attention to the gut microbiota, short-chain fatty acids, gut-derived uremic toxins, potassium bioavailability, and modifiable clinical risk factors. The clinical effect of plant foods on serum potassium cannot be predicted from total potassium content alone. The Kidney Disease: Improving Global Outcomes (KDIGO) 2024 guidelines explicitly advise individualized potassium management and emphasize limiting foods rich in bioavailable potassium, especially processed foods, rather than reflexively restricting fruits and vegetables. Across CKD studies, the association between dietary potassium and serum potassium is weak or inconsistent, and the risk of hyperkalemia is modified by kidney function, bowel function, metabolic acidosis, diabetes and hyperglycemia, medications, food processing, and the food matrix itself. Potassium bioavailability varies substantially according to the food matrix, preparation method, portion size, and processing method; some minimally processed plant foods may provide less readily absorbable potassium than potassium-rich processed foods, juices, or potassium additives. Fruits, vegetables, and legumes also provide fiber, resistant starch, and polyphenols that can support saccharolytic fermentation, short-chain fatty acid production, bowel transit, and lower concentrations of some gut-derived uremic toxins. However, blood-pressure and kidney-outcome benefits in CKD are supported more strongly by observational and selected alkali-diet trials than by large microbiome-focused randomized studies. In hypertensive CKD, fruits, vegetables, and legumes should not be universally restricted simply because they contain potassium. A safer and more evidence-aligned strategy is individualized, food-source-aware prescribing that prioritizes minimally processed plant foods, accounts for preparation method and portion size, corrects constipation and acidosis, reviews potassium-raising medications and additives, and monitors serum potassium according to baseline risk. Full article

Global poultry consumption continues to rise, while worldwide bans on in-feed antibiotic growth promoters raise an urgent requirement for eco-friendly alternatives to guarantee production efficiency and food safety. Probiotics, live beneficial microorganisms that improve host intestinal health, are reviewed. We elaborate four core functional pathways of probiotics: competitive exclusion of pathogens, enhancement of intestinal barrier integrity, immune modulation and regulation of microbial metabolites such as short-chain fatty acids. Their mitigating effects against heat stress, suboptimal rearing environments, mycotoxin contamination, heavy metal exposure and immune stress are analyzed. We further evaluate the capacity of single and compound probiotics to control major poultry diseases. Early-life intervention strategies and innovative preparations (multistrain probiotics, synbiotics, postbiotics) are systematically summarized. Critical bottlenecks restricting industrial translation are highlighted, including empirical strain combination, non-standardized administration protocols, divergent evaluation indicators and single-factor laboratory challenge models inconsistent with actual farm conditions. Finally, we propose future research directions covering multi-omics-assisted strain screening, optimized delivery technology, unified industrial quality control standards and field verification under compound stress. This review offers integrated references for mechanistic research, strain development and precise industrial application of probiotics in sustainable antibiotic-free poultry breeding. Full article